戻る
Standard BioTools Inc (LAB) 収入
LAB 株価推移チャート
LAB 収入
Standard BioTools Inc
$0.9
-1.13%
$-0.01
終値： Apr 02, 16:00:00 GMT-4
$0.9
0%
$0
アフターマーケット：Apr 02, 20:00:00 GMT-4
最新の利益結果: Q4 '25
報告済み: 2026-02-24
歴史的収益
四半期
年次
EPS
収入
Earnings FAQ
LABの最近の1株当たり利益（EPS）は予想と比較してどうでしたか？
Standard BioTools Inc LABの前四半期の収益はどうでしたか？
Standard BioTools Incの収益見積もりはいくらですか？
Standard BioTools Incの収益品質スコアはどれくらいですか？
Standard BioTools Incはいつ収益を報告しますか？
Standard BioTools Incの予想収益はいくらですか？
Standard BioTools Incは収益予想を上回りましたか？
主要データ
前終値
$0.9183
始値
$0.8971
当日レンジ
$0.8817 - $0.9289
52週レンジ
$0.88 - $1.72
取引高
1.6M
平均取引高
1.8M
配当利回り
--
1株当たり利益(TTM)
-0.20
時価総額
$349.1M
LABとは何ですか？
Standard BioTools Inc. engages in the provision of biotechnology tools and services for clinical research. The company is headquartered in Boston, Massachusetts. The company went IPO on 2011-02-10. The firm's segments include Proteomics and Genomics. The Proteomics segment includes instruments, consumables, software, and services based upon technologies used in the identification of proteins. The Genomics segment includes instruments, consumables, software, and services based upon technologies used in the identification of genes (DNA, RNA) and their functions. The firm works with academic, government, pharmaceutical, biotechnology, plant and animal research, and clinical laboratories worldwide, focusing on the most pressing needs in translational and clinical research, including oncology, immunology, and immunotherapy. The company offers a diverse range of instrumentation, consumables, and services that generate data across early discovery, translational and clinical research.